These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 25398103)

  • 1. Sepsis biomarkers. Value and limitations.
    Vincent JL; Teixeira L
    Am J Respir Crit Care Med; 2014 Nov; 190(10):1081-2. PubMed ID: 25398103
    [No Abstract]   [Full Text] [Related]  

  • 2. No significant reduction in antibiotic treatment using a procalcitonin algorithm with low cutoff value in the intensive care unit?
    Kloosterboer SM; van Zanten AR
    Am J Respir Crit Care Med; 2015 Apr; 191(7):858-9. PubMed ID: 25830524
    [No Abstract]   [Full Text] [Related]  

  • 3. Reply: No significant reduction in antibiotic treatment using a procalcitonin algorithm with low cutoff value in the intensive care unit?
    Shehabi Y; Rachakonda KS; Bailey MJ; Peake S
    Am J Respir Crit Care Med; 2015 Apr; 191(7):859-60. PubMed ID: 25830525
    [No Abstract]   [Full Text] [Related]  

  • 4. [In CNS symptoms remember: sepsis is an encephalopathy!].
    Bischoff A
    MMW Fortschr Med; 2012 Oct; 154(18):28. PubMed ID: 23156865
    [No Abstract]   [Full Text] [Related]  

  • 5. Procalcitonin algorithm in critically ill adults with undifferentiated infection or suspected sepsis. A randomized controlled trial.
    Shehabi Y; Sterba M; Garrett PM; Rachakonda KS; Stephens D; Harrigan P; Walker A; Bailey MJ; Johnson B; Millis D; Ding G; Peake S; Wong H; Thomas J; Smith K; Forbes L; Hardie M; Micallef S; Fraser JF; ;
    Am J Respir Crit Care Med; 2014 Nov; 190(10):1102-10. PubMed ID: 25295709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Procalcitonin: potential role in diagnosis and management of sepsis.
    Rowland T; Hilliard H; Barlow G
    Adv Clin Chem; 2015; 68():71-86. PubMed ID: 25858869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Daily monitoring of biomarkers of sepsis in complicated long-term ICU-patients: can it support treatment decisions?
    Iapichino G; Marzorati S; Umbrello M; Baccalini R; Barassi A; Cainarca M; Colombo Pavini F; Mantovani E; Mauri A; Moroni B; Noto A; Melzi D'Eril GV; Langer M
    Minerva Anestesiol; 2010 Oct; 76(10):814-23. PubMed ID: 20935617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can procalcitonin levels guide antibiotic therapy in bacterial infections and reduce antibiotic overconsumption without having a negative effect on clinical outcomes?
    Sandifer JP; Jones AE
    Ann Emerg Med; 2012 Sep; 60(3):370-1. PubMed ID: 22305332
    [No Abstract]   [Full Text] [Related]  

  • 9. A PCT algorithm for discontinuation of antibiotic therapy is a cost-effective way to reduce antibiotic exposure in adult intensive care patients with sepsis.
    Kip MM; Kusters R; IJzerman MJ; Steuten LM
    J Med Econ; 2015; 18(11):944-53. PubMed ID: 26105574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Procalcitonin-guided algorithms of antibiotic therapy in the intensive care unit: a systematic review and meta-analysis of randomized controlled trials.
    Kopterides P; Siempos II; Tsangaris I; Tsantes A; Armaganidis A
    Crit Care Med; 2010 Nov; 38(11):2229-41. PubMed ID: 20729729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Procalcitonin as a diagnostic and prognostic biomarker of sepsis in critically ill children.
    Leclerc F; Cremer R; Noizet O
    Pediatr Crit Care Med; 2003 Apr; 4(2):264-6. PubMed ID: 12749670
    [No Abstract]   [Full Text] [Related]  

  • 12. Procalcitonin-guided therapy in severe sepsis and septic shock. Authors' response.
    Schlattmann P; Brunkhorst FM
    Crit Care; 2014 May; 18(3):427. PubMed ID: 25473656
    [No Abstract]   [Full Text] [Related]  

  • 13. Is procalcitonin-guided antimicrobial use cost-effective in adult patients with suspected bacterial infection and sepsis?
    Harrison M; Collins CD
    Infect Control Hosp Epidemiol; 2015 Mar; 36(3):265-72. PubMed ID: 25695167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using procalcitonin to guide antimicrobial duration in sepsis: asking the same questions will not bring different answers.
    Salluh JI; Nobre V; Povoa P
    Crit Care; 2014 May; 18(3):142. PubMed ID: 25032999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Procalcitonin-guided therapy in severe sepsis and septic shock.
    Gu WJ; Liu JC
    Crit Care; 2014 May; 18(3):427. PubMed ID: 25033407
    [No Abstract]   [Full Text] [Related]  

  • 16. Host response biomarkers in sepsis: the role of procalcitonin.
    Vincent JL; Van Nuffelen M; Lelubre C
    Methods Mol Biol; 2015; 1237():213-24. PubMed ID: 25319789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biomarkers in the critically ill patient: procalcitonin.
    Reinhart K; Meisner M
    Crit Care Clin; 2011 Apr; 27(2):253-63. PubMed ID: 21440200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antibiotics or not--procalcitonin can guide therapeutic choices. At least at the emergency department for adults with lower respiratory tract infection].
    Ternhag A; Cars O; Norman C; Struwe J
    Lakartidningen; 2010 Apr 14-20; 107(15):985-8. PubMed ID: 20464915
    [No Abstract]   [Full Text] [Related]  

  • 19. Use of procalcitonin-guided decision-making to shorten antibiotic therapy in suspected neonatal early-onset sepsis: prospective randomized intervention trial.
    Stocker M; Fontana M; El Helou S; Wegscheider K; Berger TM
    Neonatology; 2010; 97(2):165-74. PubMed ID: 19776651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibiotics in intensive care: too little or too much?
    Johansen ME; Jensen JU; Lundgren JD
    Crit Care Med; 2011 Jul; 39(7):1849-51. PubMed ID: 21685762
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.